These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8951217)

  • 1. Impact of Cancer Biotechnology on Diagnostic and Prognostic Indicators in Predictive Oncology and Therapy. Nice, France, October 26-28, 1996. Abstracts.
    Cancer Detect Prev; 1996; 20(5):391-555. PubMed ID: 8951217
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Biotechnology on Predictive Oncology and Therapy: Biomedical Diagnostic and Predictive Indicators. International symposium. Boston, December 11-13, 1994. Abstracts.
    Cancer Detect Prev; 1995; 19(1):1-141. PubMed ID: 7600557
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic and predictive factors for breast cancer: translating technology to oncology.
    Hayes DF
    J Clin Oncol; 2005 Mar; 23(8):1596-7. PubMed ID: 15755959
    [No Abstract]   [Full Text] [Related]  

  • 4. 10 years and counting: the hype and hope of cancer biotechnology.
    Morris K
    Lancet Oncol; 2002 Oct; 3(10):582. PubMed ID: 12372706
    [No Abstract]   [Full Text] [Related]  

  • 5. Innovative therapies in hematology and oncology.
    Hanson DS; Brooks BJ
    Med Clin North Am; 1992 Sep; 76(5):1169-84. PubMed ID: 1518333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
    Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer at the crossroads.
    Lumsdon K; Anderson HJ
    Hospitals; 1992 Dec; 66(23):22-30. PubMed ID: 1446906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fantastic voyage: the future of cancer diagnostics.
    Sundaresan TK; Haber DA
    Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic, prognostic and therapeutic optimization in oncology. XIIth Grenoble Oncology meeting. 30-31 March 1995].
    Bull Cancer; 1995 Dec; 82 Suppl 5():510s-611s. PubMed ID: 8680056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4th International Symposium on Predictive Oncology and Therapy. Nice, France, October 24-27, 1998. Abstracts.
    Cancer Detect Prev; 1998; 22 Suppl 1():S57-287. PubMed ID: 10021890
    [No Abstract]   [Full Text] [Related]  

  • 13. Back and forth between cancer treatment and cancer control programs: Insights from the Cuban experience.
    Lage A; Romero T
    Semin Oncol; 2018 Jan; 45(1-2):12-17. PubMed ID: 30318079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MR Imaging in Oncology.
    Mukherji SK
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):xv. PubMed ID: 26613886
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer heterogeneity, patient diversity and next-generation cognitive computing.
    Makhoul I
    J Ark Med Soc; 2016 Dec; 113(6):126. PubMed ID: 30047671
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR Imaging Biomarkers in Oncology Clinical Trials.
    Abramson RG; Arlinghaus LR; Dula AN; Quarles CC; Stokes AM; Weis JA; Whisenant JG; Chekmenev EY; Zhukov I; Williams JM; Yankeelov TE
    Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):11-29. PubMed ID: 26613873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple biomarkers in molecular oncology.
    Johann DJ; Veenstra TD
    Expert Rev Mol Diagn; 2007 May; 7(3):223-5. PubMed ID: 17489728
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology: its impact on medicine and oncology.
    Borden EC
    Ann Acad Med Singap; 1991 Mar; 20(2):255-9. PubMed ID: 1715679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics in paediatric oncology: a potential still to be exploited.
    Spiga L; Atzori L; Noto A; Moretti C; Mussap M; Masile A; Lussu M; Fanos V
    J Matern Fetal Neonatal Med; 2013 Oct; 26 Suppl 2():20-3. PubMed ID: 24059547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.